Company Filing History:
Years Active: 2004
Title: Rolf Knippers: Innovator in Monoclonal Antibodies
Introduction
Rolf Knippers is a notable inventor based in Konstanz, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for the prevention and treatment of diseases associated with the human Mcm3 protein.
Latest Patents
Rolf Knippers holds a patent for "Monoclonal antibodies against human protein Mcm3, process for their production, and their use." This invention relates to monoclonal antibodies that specifically detect and bind to the human Mcm3 protein. The patent outlines hybridoma cell lines that produce these antibodies, as well as the procedures for their production. The antibodies have potential applications in pharmaceutical compositions for preventing and treating diseases linked to Mcm3 expression.
Career Highlights
Throughout his career, Rolf Knippers has been associated with Dakocytomation Denmark A/S, where he has contributed to advancements in immunological research. His expertise in monoclonal antibodies has positioned him as a key figure in the biotechnology sector.
Collaborations
Rolf has collaborated with notable colleagues such as Johannes Gerdes and Thomas Scholzen. These partnerships have enhanced the research and development of innovative solutions in the field of monoclonal antibodies.
Conclusion
Rolf Knippers is a distinguished inventor whose work on monoclonal antibodies has the potential to impact medical science significantly. His contributions continue to pave the way for advancements in disease prevention and treatment.